Instil Bio, Inc.
TIL
$28.41
$2.7010.50%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 6.16M | 9.11M | 12.49M | 10.71M | 10.71M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.90M | 14.48M | 15.38M | 11.27M | 13.63M |
| Operating Income | -12.90M | -14.48M | -15.38M | -11.27M | -13.63M |
| Income Before Tax | -21.39M | -28.20M | -11.90M | -23.02M | -14.92M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -21.39M | -28.20M | -11.90M | -23.02M | -14.92M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -21.39M | -28.20M | -11.90M | -23.02M | -14.92M |
| EBIT | -12.90M | -14.48M | -15.38M | -11.27M | -13.63M |
| EBITDA | -12.89M | -13.98M | -14.64M | -10.37M | -12.65M |
| EPS Basic | -3.24 | -4.32 | -1.82 | -3.54 | -2.29 |
| Normalized Basic EPS | -1.03 | -1.16 | -1.48 | -1.02 | -1.38 |
| EPS Diluted | -3.24 | -4.32 | -1.82 | -3.54 | -2.29 |
| Normalized Diluted EPS | -1.03 | -1.16 | -1.48 | -1.02 | -1.38 |
| Average Basic Shares Outstanding | 6.60M | 6.53M | 6.53M | 6.50M | 6.50M |
| Average Diluted Shares Outstanding | 6.60M | 6.53M | 6.53M | 6.50M | 6.50M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |